Functional Characterization Experiment summary for ENCSR048GGL

doi:10.17989/ENCSR048GGL

Summary

Status
released
Assay
CRISPR screen (Control CRISPR screen)
Control type
control
Biosample summary
Homo sapiens K562 genetically modified (insertion) using transduction (low MOI), using CRISPR cutting (sgRNA) for MYC locus
Biosample Type
cell line
Perturbation type
CRISPR cutting
Tiling modality
peak tiling
Replication type
isogenic
Description
Control for CRISPR screen targeting candidate CREs
Treatments
Puromycin (CHEBI:17939)
Nucleic acid type
DNA
Elements references

Attribution

ENCODE4 project
Lab
Yin Shen, UCSF
Award
UM1HG009402 (Yin Shen, UCSF)
Project
ENCODE
Aliases
yin-shen:DCC_K562_MYC_GFP_MYC_Screening_T0_Experiment
Date released
August 30, 2021
Functional Characterization Series
ENCSR261PJJ 
, ENCSR042KBK 

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Modifications
Library
11Homo sapiens K562 cell line genetically modified (insertion) using transduction (low MOI), genetically modified using CRISPR cutting (sgRNA) 0 days after the sample was treated with PuromycinENCBS037ZGTENCGM063WJB, ENCGM885GEZENCLB556RJH
21Homo sapiens K562 cell line genetically modified (insertion) using transduction (low MOI), genetically modified using CRISPR cutting (sgRNA) 0 days after the sample was treated with PuromycinENCBS490LVPENCGM063WJB, ENCGM885GEZENCLB889FPR